• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Support Comes From Many Directions

  • Fri, 1/6/12 - 3:37pm
  • 689 reads
  • 0 comments

A 65-year-old male presented with angina pectoris. Five months prior to this procedure, attempted recanalization of his right coronary artery was performed unsuccessfully. He presented with recurrent angina. His risk factors included hyperlipidemia and diabetes mellitus. He also had a previous PTCA of the ramus in 2008. The patient’s right coronary artery showed ipsilateral collaterals and a right radial approach was attempted. We did not place a contralateral catheter. After local anesthesia, radial access was performed and the 5 Fr diagnostic Jacky™ catheter was inserted through the 6 Fr sheath. For recanalization of the right coronary artery, a 6 Fr Ikari right 2.0 guide catheter was utilized. The   wire was inserted through the guiding catheter; however, due to poor guide support, a Sprinter® over-the-wire balloon was inflated proximally. The wire was then passed across the proximal portion of the CTO. We exchanged the balloon catheter for a FineCross™ support catheter and after further advancement of the wire, it was exchanged for a Fielder XT wire. The Fine Cross was exchanged for a 1.25 x 6 mm over-the-wire balloon and we switched to the GuideLiner system due to continued poor support. Next, the Sprinter® Legend balloon was passed with GuideLiner support and multiple balloon inflations. We then placed 6 Endeavor stents; 3.0 distally up to 3.5 proximally. It was clear there was thrombus present in the vessel so we passed a Whisper wire across the total occlusion distally and the Export® catheter was advanced with clot removed. Activated clotting times (ACTs) were followed and were over 200 with repeated doses of heparin. At the end of the procedure TIMI III flow was obtained. There was 0% residual stenosis. We performed radial compression and the stenosis went from 100% to 0%. 

This is a case where the guiding catheter support with an anchoring balloon was effective, but was not as effective as utilization of the GuideLiner to further cross the 100% occlusion. In many CTOs, we also use aspiration because even though this appears to be a chronic occlusion, sometimes thrombus is present at the end of the procedure. It is important to make sure that you follow ACTs on a 30-minute basis and utilize such thrombus aspiration catheters as the Export®, which was used effectively in this case. The patient is now 2 months post-procedure, free of angina.

Product credits:Jacky™ catheter, Ikari guide catheter, FineCross™ support catheter (Terumo Medical)
Provia wire, Sprinter® Legend RX Semicompliant Balloon and Semi-Compliant Over-the-Wire Balloon Dilatation Catheter, Export® AP Aspiration Catheter (Medtronic Medical)
Fielder XT wire, Hi-Torque Whisper (Abbott)
GuideLiner system (Vascular Solutions)

Figure 1. The RCA in a LAO projection is totally occluded.

 

 

 

Figure 2. The RCA with the anchoring balloon in place with passage across the proximal cap of the CTO.

 

 

  

Figure 3. The CTO is still being crossed for further support with the GuideLiner.

 

 

 

 Figure 4. The GuideLiner has allowed completed crossing of the CTO.

 

 

 

Figure 5. The RCA prior to the use of the Export® catheter.

 

 

 

Figure 6. Final angiogram after stenting.

 

 

 

Figure 7. Distal recanalized RCA after stenting.

image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

When Will U.S. See New Lower Limb Devices?

Lawrence A. Garcia MD

Bridge To Nowhere

John E. Lassetter MD FACC FSCAI

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Medtronic Resolute Integrity Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease
    Tue, 02/21/12 - 2:25pm
  • Promising new compound for treating stroke
    Tue, 02/21/12 - 9:13am
  • HHS Announces Intent to Delay ICD-10 Compliance Date
    Fri, 02/17/12 - 2:27pm
  • Aptus Endosystems Initiates the ANCHOR Post-Market Registry
    Tue, 02/14/12 - 2:16pm
more »

Clinical Events Calendar

  • Chronic Total Occlusion Summit
    Thu, 02/23/2012 - Sat, 02/25/2012
    New York, NY, United States
  • NCVH Latin America
    Wed, 02/29/2012 - Fri, 03/02/2012
    San Jose, Costa Rica
  • Interventional Cardiology 2012: 27th Annual International Symposium
    Sun, 03/04/2012 - Fri, 03/09/2012
    Snowmass Village, CO, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications